---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-061032"
form_type: "8-K"
ticker: "LTRN"
cik: "0001763950"
company_name: "Lantern Pharma Inc."
filed_at: "2021-11-22T23:59:59+00:00"
generated_at: "2026-06-28T06:11:05.755446+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lantern Pharma announces $7M share repurchase program

## Summary
- Board authorized up to $7M of common stock repurchases.
- Cash and equivalents totaled $73.8M as of Sept 30, 2021.
- Approximately 11.2M shares outstanding as of Oct 29, 2021.
- CEO states program reflects confidence in pipeline and platform.
- Repurchases may occur on open market or privately; program can be modified.

## SEC filing metadata
- accession: 0001213900-21-061032
- form_type: 8-K
- ticker: LTRN
- cik: 0001763950
- company_name: Lantern Pharma Inc.
- filed_at: 2021-11-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763950/000121390021061032/0001213900-21-061032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763950/000121390021061032/ea151173-8k_lantern.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-061032
- JSON: https://secwatch.observer/filing/0001213900-21-061032.json
- Plain text: https://secwatch.observer/filing/0001213900-21-061032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.